rss
Br J Ophthalmol 85:1188-1197 doi:10.1136/bjo.85.10.1188
  • Original Article
    • Clinical science

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

Table 4

Results of ATP assay: mean percentage of cell viability reduction (SD) following 2 hours of incubation with test agent. 50% serum reduced the viability of cultured cells significantly less than unpreserved hypromellose (p = 0.04). 100% serum maintained cellular ATP levels better than 50% serum (p = 0.11) and serum of patients on systemic immunosuppressive therapy was less toxic than serum of healthy normal individuals (p = 0.08) although these trends did not reach statistical significance

% Viability reduction p Value (in comparison with negative control) p Value for other tests
Hypromellose 0.3% unpreserved (n = 4 tests) 87 (14) 0.03
50% serum (serum diluted 1:1 v/v with 0.5% chloramphenicol eye drops, n = 5 patients) 58 (25) 0.046 0.04 (v Hypromellose 0.3%)
100% serum of normal individual (n = 6) 34 (10) 0.03 0.11 (v 50% serum)
100% serum of patients with dry eyes treated with autologous serum (n = 4) 24 (22) 0.72
100% serum of immunosuppressed patients (n = 8) 26 (7) 0.17 0.08 (v serum of normal individuals)

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.